Classic ureteropelvic junction obstruction is defined as congenital hydronephrosis characterized by impaired urine flow from renal pelvis into proximal ureter (
12). This is a common renal anomaly in children with an incidence of 1 in 1500, and is the most common cause of hydronephrosis detected prenatally (
11). Other clinical features include symptoms of urinary tract infection, abdominal, flank or back pain, palpable renal mass in a newborn or infant and hematuria after minimal trauma (
12,
13). UPJO usually is secondary to intrinsic fibrotic narrowing of UP junction; in 20% of cases there is an accessory renal artery supplying the lower pole of the kidney that compresses the ureter.
UPJ obstruction is more commonly (60%) found on the left side, is more common in males than in females (2:1) and occurs bilaterally in 20 to 40% of affected children in some reported series (
14).
In our study also the left kidney was more commonly involved than the right; male: female ratio was 3:1.
Ultrasonography of urinary system constitutes a cornerstone in the evaluation of renal obstructive disorders. Sonographic examination, however, is operator dependent. The degree of hydronephrosis is used to assist in decision making with regard to management and some prognostic information. However, controversy exists over size cutoffs and significant pathology.
Several methods are used to diagnose upper urinary tract obstruction, the central ones being ultrasonography (US), intravenous pyelogram (IVP) diuretic renal scan and contrast enhanced MRU.
US has many attributes which make it ideal as an initial method for detecting urinary obstruction. It is noninvasive, quick, and portable, requires neither radiographic contrast media nor ionizing radiation and is relatively inexpensive. However, traditional US provides no physoiological or functional data about obstruction. Dehydration, oliguria, and low GFR state of healthy newborns deliver false negative findings. It is also criticized as not being specific for dilatation of renal collecting system. Many conditions rather than obstruction can cause renal dilatation and hence a false-positive result, e.g. extrarenal pelvis, prominent renal vasculature, residual dilatation from previous obstruction, vesicoureteral reflux, congenital megacalycosis, bladder distention and pyelonephritis (
15). In addition, hydronephrosis can be found in asymptomatic children with a reported prevalence of 0.19% in school children by portable ultrasound screening (
16). In our study, all children had sonographically moderate to severe hydronephrosis without ureter dilatation. Therefore, to increase the diagnostic accuracy of tools to differentiate between obstructive and non obstructive hydronphrosis, other methods are essential.
Although in a number of urological centers DR is commonly used to diagnose UPJO, in others IVP is used as it is considered an equally reliable test (
9,
17). Each of the methods has its limitations and each may yield false positive or false negative results. When performing DR special attention should be paid to proper patient preparation, radiopharmaceutical selection, furosemide dosage, and image interpretation to ensure accurate diagnosis.
According to Campbell-Walsh Urology “Excretory urography remains a reasonable first-line option for radiographic diagnosis” of UPJO (
18). Urologists using this test to diagnose UPJO report that in most cases IVP allows the anatomic and qualitative functional assessment necessary for the diagnosis and makes it possible to avoid costly imaging studies like a CT angiogram or DR (
9).
It seems that diuretic urography in particular is a most valuable test for preoperative and postoperative evaluation of patients with UPJO because the combination of contrast and furosemide creates maximal diuresis, and such “supranormal” conditions are highly conducive to unmasking and documenting UPJ obstruction. Excretory urography makes it possible to evaluate the degree of hydronephrosis; to identify anatomical abnormalities such as a duplicated collecting system or high ureteral insertion; to detect the crossing vessel in many cases (there are usually distinctive radiographic features); and to plan appropriate treatment. However, although IVP helps in the qualitative evaluation of the obstruction, quantitative assessment of it can be difficult (
19).
In our study, based on DR findings, diagnosis of significant UPJO could be confirmed in 46 out of 153 hydronephrotic cases. Corresponding results of US and DR were found in 37% of cases. 46 cases had criteria of significant UPJO in DR and 42 patients in DU.
Historically the IVP has been the classic imaging modality for evaluation of the upper urinary tract. Although with advances in imaging technology the indications for IVP have diminished for a number of clinical situations, it remains an extremely valuable study (
20,
21), especially in places where no advanced imaging facilities are available, therefore in some centers IVP is substituted for the diuretic renography (
22,
23).
The role of IVP in the anatomical depiction of renal obstruction such as UPJO is crucial. Collecting system dilatation, with parenchymal changes in the nephrogram and delay in excretion of contrast medium, is characteristic of obstruction (
24).
Signs of acute obstruction on IVP are well recognized and include delayed appearance of a persistently dense nephrogram, detrimental changes of parenchyma and delayed excretion of radiocontrast material. Dilatation of the collecting system is less impressive than in chronic obstruction. However, bowel preparation is needed for a better visualization and delayed films, even up to 24 hours, may be required (
2). In assessment of the 46 patients in our series the sensitivity of standardized IVP with furosemide injection for UPJO diagnosis was 91.3%. In Tsai’s study the sensitivity of IVP for diagnosis of UPJO was apparent in only half of patients (
25) and in another study DR confirmed UPJO in 35 out of 40 cases that had criteria of significant UPJO in DU (
10), which was not in agreement with our study, that maybe due to not using intravenous furosemide in IVP procedure in their study.
IVP has significant limitation in the evaluation of hydronephrosis in patients with a poorly functioning kidney, the newborn period and extremely dilated pelvis (
25). Allergic reactions, aggravation of pain and acute renal failure induced by contrast media have been reported (
2). In the current study, we observed no complications with IVP.
In nuclear medicine, renal scans are more commonly used than urography as a method of choice to diagnose obstruction in the setting of hydronephrosis. Renography can quantify individual and relative renal function, cortical transit time, and the ante-grade drainage of the collecting systems before and after the administration of furosemide. Technetium-99 m diethylene triamin pentaacetic acid (DTPA) is usually used for detection of upper urinary tract obstruction. A bladder catheter should be inserted, especially if VUR and/or suspected UVJO are present (
12,
26).
Obstruction at the UPJ is reflected by the half time to washout radioisotope-labeled urine and percentage of tracer retained within the renal pelvis or distal ureter beyond approximately 20 minutes. In the hydronephrotic system, if a quick washout occurs after the furosemide is given, the patient is said to have a dilated, non obstructive system. Prolonged washout times in functioning kidney may support the diagnosis of significant obstruction (
27). Evaluating the results of DR, it has been noted that even in technically satisfactory studies, false positive results can result from poor renal function (single kidney glomerular filtration rate < 15 mL/min) and/or huge-capacity systems (
28). False negative findings are less common than false positives (
10), but they have been observed in both animal experimental models and in clinical practice (
29,
30). O’Reilly et al noted that such results “can occur in highly compliant (small volume, ‘tight’) renal pelves, or when there is powerful high-pressure diuresis through partially obstructed systems” (
28).
In our study, all of the patients had a significant delay in drainage after injection of furosemide. The sensitivity of DR and DU in UPJO diagnosis was 100% and 91.3% in order of frequency.
We hope the study has shown that diagnosing UPJO on the basis of US and DR may result in overdiagnosis; on the other hand, US and DU may give false negative results.
Same as our study, Macleod, compared intravenous pyelography and DTPA scan for assessment of renal function and renal damage, and concluded that the computer processed data in diuretic isotope renal scan gives better results both in the recognition of morphological defects and in the indication and measurement of renal damage (
31).
Ebel believed that diuretic urography is more useful during post-operative follow up of UPJO and diuretic renography is useful after 6 months of follow up (
32). Lack of availability of surgical findings and post operative follow up was limitations to our study.
Also dynamic contrast enhanced MRU appears to provide superior anatomic details compared with renal ultrasound, nuclear scintigraphy and urography, and has no ionizing radiation. However, it is not available at many centers with limited facilities.
Both DR and IVP with furosemide injection are useful for diagnosis of upper urinary tract obstruction such as UPJO. Because of less sensitivity for diagnosis, and complications of IVP such as allergic reactions, aggravation of pain and acute renal failure induced by contrast media and more radiation than DR, DTPA diuretic renal scan for UPJO diagnosis in children is the best alternative method and highly recommended. However in many hospital facilities recent imaging technology is not easily accessible whereas urography is available; therefore, this imaging procedure maybe a useful and appropriate method for diagnosis and following up of upper urinary obstructive lesions in these settings. The authors conclude that excretory urography still remains a valuable test in diagnosing UPJO in patients with near normal renal function or in no deterioration of DRF in the affected kidney over time.